At Sarah Cannon, the many ways we fight cancer together is what sets us apart. With 200+ unique agents in trial each year, more than 250 first-in man trials conducted and more than two-thirds of approved cancer therapies featuring Sarah Cannon as a clinical trial leader over the last 10 years, Sarah Cannon is a global leader in cancer research. We bring the most innovative medical minds and resources to advance science and deliver personalized, compassionate care.

Trial availability may fluctuate, please email and one of our askSARAH representatives can assist you.